Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research.
产品描述 | IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research. |
靶点活性 | IDO1 (SKOV3 cells):6.1 nM (IC50) |
体外活性 | IDO1-IN-7 exhibits moderate potency in a human whole blood assay with an IC 50 of 330 nM[1]. IDO1-IN-7 shows a favorable profile such as good metabolic stability and acceptable off-target selectivity[1]. IDO1-IN-7 shows a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO) (IC 50 =14,000 nM)[1]. |
体内活性 | IDO1-IN-7 (10 mg/kg; p.o.) shows C max =10.0 μM, AUC 0-8 h =27.1 μM*h, t 1/2 =1.4 h in mouse[1]. Animal Model: Mouse[1]Dosage: 10 mg/kg (Pharmacokinetic Analysis) Administration: Oral administration Result: C max (10.0 μM), AUC 0-8 h (27.1 μM*h), t 1/2 (1.4 h) |
别名 | IDO1-IN-7 |
分子量 | 427.86 |
分子式 | C22H19ClFN3O3 |
CAS No. | 2351199-98-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IDO1-IN-7 2351199-98-7 IDO1IN7 IDO-1-IN-7 IDO1 IN 7 Inhibitor inhibitor inhibit